PART I Overview Chemicals are ubiquitous in modern life - they form the basis of medicines, fuels, plastics, food, and colors, among many other applications that together contribute to our ability to live the good life in the modern world. Harvesting chemicals from nature via traditional extraction methods is often inefficient and often requires large amounts of biological material to extract the necessary amounts of the desired chemical compounds. So, despite maybe being sustainable, it is not ...
Q2 FY2026 — expected 2026-07-17
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-30 | 2025-12-31 | 0001493152-26-013563 | EDGAR | 54K words |
| 2025-03-31 | 2024-12-31 | 0001641172-25-001744 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-13 | 2025-09-30 | 0001493152-25-022289 | EDGAR | 20K words |
| 2025-08-12 | 2025-06-30 | 0001641172-25-023184 | EDGAR | — |
| 2025-05-12 | 2025-03-31 | 0001641172-25-009636 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0001493152-24-044813 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-31 | 0001493152-26-013733 | EDGAR | 0K words |
| 2026-02-05 | 0001493152-26-005176 | EDGAR | — |
| 2025-12-12 | 0001493152-25-027327 | EDGAR | — |
| 2025-11-13 | 0001493152-25-022295 | EDGAR | — |
| 2025-10-03 | 0001493152-25-016831 | EDGAR | — |
| 2025-07-28 | 0001641172-25-021084 | EDGAR | — |
| 2025-07-08 | 0001641172-25-018053 | EDGAR | — |
| 2025-06-26 | 0001641172-25-016681 | EDGAR | — |
| 2025-06-20 | 0001641172-25-015782 | EDGAR | — |
| 2025-04-02 | 0001641172-25-002396 | EDGAR | — |
31 total filings indexed. 15 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0002010788 |
| Ticker | EXOZ |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | NV |
| Website | https://www.exozymes.com |
| Listed | 2024-11-13 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report